User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

T-cell-recognized Antigenic Peptides Derived From the Cellular Genome Are Not Protein-degradation Products But Can Be Generated Directly By Transcription and Translation of Short Subgenic Regions - a Hypothesis

  1. Allen P. M., Strydom, D., and Unanue, E. R.: Processing of lysozyme by macrophages: identification of the determinant recognized by two T cell hybridomas. Proc Natl Acad Sci USA 81: 2489?2493, 1984
  2. Babbitt, B., Allen, P., Matsueda, G., Haber, E., and Unanue, E. R.: Binding of immunogenic peptides to la histocompatibility molecules. Nature 317: 359?361, 1985
  3. Bevan, M. J.: Interaction antigens detected by cytotoxic T cells with the major histocompatibility complex as modifier. Nature 256: 419?421, 1975
  4. Bjorkman, P. J., Saper, M. A., Samraoui, B., Bennett, W. S., Strominger, J. L., and Wiley, D. C.: The foreign antigen biding site and T cell recognition regions of class I histocompatibility antigens. Nature 329: 512?518 1987
  5. Boon, T.: Antigenic tumor cell variants obtained with mutagens. Adv Cancer Res 39: 121?151, 1983
  6. Boon, T. and Kellermann, O.: Rejection by syngeneic mice of cell variants obtained by mutagenesis of a malignant teratocarcinoma cell line. Proc Natl Acad Sci USA 74: 272?275, 1977
  7. Buus, S., Sette, A., Colon, S., Jenis, D., and Grey, H.: Isolation and charcterization of antigen-Ia complexes involved in T cell recognition. Cell 47: 1071?1077, 1986
  8. Buus, S., Sette, A., Colon, S., Miles, C., and Grey, H. M.: The relaton between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides. Science 235: 1353?1358, 1987
  9. de Duve, C. and Wattiaux, R.: Functions of lysosomes. Annu Rev Physiol 28: 435?492, 1966
  10. De Plaen, E., Lurquin, C., Van Pel, A., Mariamé, B., Szikora, J.-P., Wölfel, T., Sibille, C., Chomez, P., and Boon, T.: Immunogenic (turn?) variants of mouse tumor P815: cloning of the gene of turn? antigen P91A and identification of the turn- mutation. Proc Natl Acad Sci USA 85: 2274?2278, 1988
  11. Frost, P., Kerbel, R., Bauer, E., Tartamella-Biondo, R., and Cefalu, W.: Mutagen treatment as a means for selecting immunogenic variants from otherwise poorly immunogenic malignant murine tumors. Cancer Res 43: 125?132, 1983
  12. Hämmerling, U. and Eggers, H. J.: Quantitative measurements of uptake of alloantibody on mouse lymphocytes. Eur J Biochem 17: 95?99, 1970
  13. Hedrick, S., Cohen, D., Nielsen, E., and Davis, M.: Isolation of cDNA encoding T cell-specific membrane-associated proteins. Nature 308: 149?153, 1984
  14. Kappler, J., Kuhn, R., Haskins, K., Hannum, C., Marrack, P., Pigeon, M., Mc Intire, B., Allison, J., and Trowbridge, I.: The major histocompatibility complex-restricted antigen receptor on T cells in mouse and man: identification of constant and variable peptides. Cell 35: 295?302, 1983
  15. Maryanski, J. L., Van Snick, J., Cerottini, J.-C., and Boon, T.: Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. III. Clonal analysis of the syngeneic cytolytic T lymphocyte response. Eur J Immunol 12: 401?406, 1982
  16. Maryanski, J. L., Pala, P., Corradin, G., Jordan, B. R., and Cerottini, J.-C.: H-2-restricted cytolytic T cells specific for HLA can recognize a synthetic HLA peptide. Nature 324: 578?579, 1986
  17. Shimonkevitz, R., Kappler, J., Marrack, P., and Grey, H. M.: Antigen recognition by H-2 restricted T cells. 1. Cell-free antigen processing. J Exp Med 158: 303?316, 1983
  18. Shimonkevitz, R., Colon, S., Kappler, J., Marrack, P., and Grey, H. M.: Antigen recognition by H-2 restricted T cells. A tryptic ovalbumin peptide that substitutes for processed antigen. J Immunol 133: 2067?2074, 1984
  19. Townsend, A., Gotch, F., and Davey, J.: Cytotoxic T cells recognize fragments of the influenza nucleoprotein. Cell 42: 457?467, 1985
  20. Townsend, A., Bastin, J., and Brownlee, G.: Cytotoxic T lymphocytes recognize influenza hemagglutinin that lacks a signal sequence. Nature 324: 575?577, 1986a
  21. Townsend, A., Rothbard, J., Gotch, F., Bahadur, G., Wraith, D., and McMichael,J.: The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44: 959?968, 1986b
  22. Uyttenhove, C., Van Snick, J., and Boon, T.: Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. I. Rejection by syngeneic mice. J Exp Med 152: 1175?1183, 1980
  23. Wabuke-Bunoti, M., Taku, A., Fan, D., Kent, S., and Webster, R.: Cytolytic T lymphocyte and antibody responses to synthetic peptides of influenza virus hemagglutinin. J Immunol 133: 2194?2201, 1984
  24. Wölfel, T., Van Pel, A., De Plaen, E., Lurquin, C., Maryanski, J. L., and Boon, T.: Immunogenic (turn?) variants obtained by mutagenesis of mouse mastocytoma P815. VIII. Detection of stable transfectants expressing a turn? antigen with cytolytic T cell stimulation assay. Immunogenetics 26: 178?187, 1987
  25. Yanagi, Y., Yoshikai, Y., Leggett, K., Clark, S., Aleksander, I., and Mak, T.: A human T cell-specific cDNA clone encodes a protein having extensive homology to immunoglobulin chain. Nature 308: 145?149, 1984
  26. Ziegler, H. K. and Unanue, E. R.: Decrease in macrophage antigen catabolism by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells. Proc Natl Acad Sci USA 79: 175?178, 1982
  27. Zinkernagel, R. and Doherty, P.: Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature 248: 701?702, 1974
Bibliographic reference Boon, Thierry ; Van Pel, Aline. T-cell-recognized Antigenic Peptides Derived From the Cellular Genome Are Not Protein-degradation Products But Can Be Generated Directly By Transcription and Translation of Short Subgenic Regions - a Hypothesis. In: Immunogenetics, Vol. 29, no. 2, p. 75-79 (1989)
Permanent URL http://hdl.handle.net/2078.1/52617